肿瘤药物-话题@MedSci

#肿瘤药物#

90篇内容 | 3544人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1446764, encodeId=38351446e649a, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=抗肿瘤药物的时间“罗盘”, objectType=article, longId=92210, objectId=eec192210cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eec192210cb, replyNumber=0, likeNumber=79, createdTime=2017-03-19, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eec192210cb, moduleTitle=抗肿瘤药物的时间“罗盘”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eec192210cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446763, encodeId=5ff71446e63b7, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送, objectType=article, longId=86714, objectId=250186e14f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250186e14f7, replyNumber=0, likeNumber=73, createdTime=2017-01-07, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250186e14f7, moduleTitle=Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250186e14f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446762, encodeId=58551446e62d5, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, objectType=article, longId=76273, objectId=3d4be6273e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4be6273e6, replyNumber=0, likeNumber=36, createdTime=2016-09-01, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4be6273e6, moduleTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4be6273e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446761, encodeId=0e2f1446e6156, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=未来5年畅销的抗肿瘤药物TOP10, objectType=article, longId=75388, objectId=e37be538834, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37be538834, replyNumber=0, likeNumber=59, createdTime=2016-08-19, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37be538834, moduleTitle=未来5年畅销的抗肿瘤药物TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e37be538834)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446760, encodeId=c1941446e608c, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=肿瘤药物研发大潮的驱动力及潜在风险, objectType=article, longId=72150, objectId=121de215014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121de215014, replyNumber=0, likeNumber=55, createdTime=2016-07-07, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121de215014, moduleTitle=肿瘤药物研发大潮的驱动力及潜在风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121de215014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446759, encodeId=e9ba1446e5939, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=ASCO 2016：肿瘤药物的五大趋势, objectType=article, longId=70427, objectId=ea6ee04271c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea6ee04271c, replyNumber=0, likeNumber=64, createdTime=2016-06-12, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea6ee04271c, moduleTitle=ASCO 2016：肿瘤药物的五大趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea6ee04271c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446758, encodeId=df471446e58c7, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, objectType=article, longId=64929, objectId=dfc664929a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc664929a1, replyNumber=0, likeNumber=72, createdTime=2016-03-18, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc664929a1, moduleTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfc664929a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446757, encodeId=b2fc1446e57ac, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=中国抗癌协会肿瘤药物临床研究专业委员会成立, objectType=article, longId=64738, objectId=d00764e3833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00764e3833, replyNumber=0, likeNumber=59, createdTime=2016-03-16, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00764e3833, moduleTitle=中国抗癌协会肿瘤药物临床研究专业委员会成立, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00764e3833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446756, encodeId=c5251446e56b5, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=JAMA子刊：FDA肿瘤药物批准背后的利益关系, objectType=article, longId=62900, objectId=18cc629003d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18cc629003d, replyNumber=0, likeNumber=61, createdTime=2016-02-04, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18cc629003d, moduleTitle=JAMA子刊：FDA肿瘤药物批准背后的利益关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18cc629003d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446755, encodeId=f1b01446e5562, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, objectType=article, longId=59536, objectId=03c459536ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c459536ba, replyNumber=0, likeNumber=109, createdTime=2015-11-28, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c459536ba, moduleTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c459536ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446754, encodeId=ff631446e54dc, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, objectType=article, longId=57761, objectId=a0445e76182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0445e76182, replyNumber=0, likeNumber=73, createdTime=2015-10-26, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0445e76182, moduleTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0445e76182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446753, encodeId=ddc41446e53d6, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, objectType=article, longId=57302, objectId=3c895e302cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c895e302cd, replyNumber=0, likeNumber=57, createdTime=2015-10-17, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c895e302cd, moduleTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c895e302cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446752, encodeId=3d8f1446e52ae, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=ASCO 2015：全球肿瘤药物研究新近进展, objectType=article, longId=51827, objectId=fe825182e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe825182e6f, replyNumber=0, likeNumber=59, createdTime=2015-06-11, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe825182e6f, moduleTitle=ASCO 2015：全球肿瘤药物研究新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe825182e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446751, encodeId=ebd61446e5128, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=免疫肿瘤药物概述与发展, objectType=article, longId=51761, objectId=ba5251e6119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba5251e6119, replyNumber=0, likeNumber=78, createdTime=2015-06-08, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba5251e6119, moduleTitle=免疫肿瘤药物概述与发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba5251e6119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446750, encodeId=ccf41446e503a, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=ASCO 2015：肿瘤药物争夺战, objectType=article, longId=51645, objectId=efca5164540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efca5164540, replyNumber=0, likeNumber=67, createdTime=2015-06-06, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efca5164540, moduleTitle=ASCO 2015：肿瘤药物争夺战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efca5164540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446749, encodeId=16a41446e49f9, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=2014年FDA新批准的抗肿瘤药物, objectType=article, longId=46897, objectId=ef0f4689eb5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef0f4689eb5, replyNumber=0, likeNumber=72, createdTime=2015-02-12, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef0f4689eb5, moduleTitle=2014年FDA新批准的抗肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef0f4689eb5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446748, encodeId=02921446e4886, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, objectType=article, longId=46487, objectId=cb004648ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb004648ea2, replyNumber=0, likeNumber=73, createdTime=2015-02-04, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb004648ea2, moduleTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb004648ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446747, encodeId=4f5f1446e47cc, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=靶向抗肿瘤药物的命名, objectType=article, longId=46320, objectId=1bec4632027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bec4632027, replyNumber=0, likeNumber=74, createdTime=2015-01-30, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bec4632027, moduleTitle=靶向抗肿瘤药物的命名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bec4632027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446746, encodeId=37011446e46c4, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=FDA审查诺华新型血液肿瘤药物, objectType=article, longId=42428, objectId=7f704242867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f704242867, replyNumber=0, likeNumber=80, createdTime=2014-11-13, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f704242867, moduleTitle=FDA审查诺华新型血液肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f704242867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446745, encodeId=32371446e4574, content=<a href='/topic/show?id=94bd830865e' target=_blank style='color:#2F92EE;'>#肿瘤药物#</a>, objectTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, objectType=article, longId=40353, objectId=a9d940353d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9d940353d8, replyNumber=0, likeNumber=60, createdTime=2014-09-18, rootId=0, userName=smartjoy, userId=c17d5287383, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9d940353d8, moduleTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9d940353d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤药物

2020-05-29

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

抗肿瘤药物的时间“罗盘”

2017-03-19

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送

2017-01-07

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布

2016-09-01

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

未来5年畅销的抗肿瘤药物TOP10

2016-08-19

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

肿瘤药物研发大潮的驱动力及潜在风险

2016-07-07

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

ASCO 2016：肿瘤药物的五大趋势

2016-06-12

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

复旦大学抗肿瘤药物专利“天价”卖给美国公司

2016-03-18

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

中国抗癌协会肿瘤药物临床研究专业委员会成立

2016-03-16

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

JAMA子刊：FDA肿瘤药物批准背后的利益关系

2016-02-04

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%

2015-11-28

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

抗肿瘤药物尼罗替尼可能会逆转帕金森氏症

2015-10-26

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现

2015-10-17

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

ASCO 2015：全球肿瘤药物研究新近进展

2015-06-11

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

免疫肿瘤药物概述与发展

2015-06-08

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

ASCO 2015：肿瘤药物争夺战

2015-06-06

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

2014年FDA新批准的抗肿瘤药物

2015-02-12

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素

2015-02-04

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

靶向抗肿瘤药物的命名

2015-01-30

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

FDA审查诺华新型血液肿瘤药物

2014-11-13

smartjoy (审核中...)

前往app查看评论内容

#肿瘤药物#

Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新

2014-09-18

科室
- - 订阅+
  - 更多科室
工具
服务